Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity

Joanne L. Jones, Jane M. Anderson, Chia Ling Phuah, Edward J. Fox, Krzysztof Selmaj, David Margolin, Stephen L. Lake, Jeffrey Palmer, Sara J. Thompson, Alastair Wilkins, Daniel J. Webber, D. Alastair Compston, Alasdair J. Coles

Research output: Contribution to journalArticlepeer-review

148 Scopus citations

Fingerprint

Dive into the research topics of 'Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity'. Together they form a unique fingerprint.

Medicine & Life Sciences